InSilico modeling
From Wikipedia, the free encyclopedia
InSilico modelling is a form of computer-based modelling whose technologies are applied in:
- drug target identification or drug discovery processes e.g. by provision models for cancer or pathogens
- whole cell analysis of prokaryotic and eukaryotic hosts e.g. E. coli, B. subtilis, yeast, CHO- or human cell lines
- bioprocess development and optimization e.g. optimization of product yields
- analysis, interpretation and visualization of heterolous data sets from various sources e.g. genome, transcriptome or proteome data
[edit] See also
- Nonclinical studies
- Effect size
- Excipient
- Food and Drug Administration
- Good Manufacturing Practice
- Good clinical practice
- HTS
- Harmonization in clinical trials
- Institutional review board
- International Conference on Harmonisation
- Investigational product
- Multicenter trial
- Pharmaceutical project